In 2011, revenue was $7.8 million. In 2014, revenue had grown to $118.2 million. That’s more than a +1,500% increase in revenue over the last 4 years.
The last quarterly report was awesome from a growth perspective.
Highlights from the first quarter 2015 report:
Q1 2015 revenue of $40.8 million increases 108% over Q1 2014
Q1 2015 is 14th consecutive quarter of meeting or exceeding revenue guidance
Q1 2015 Wound Care sales grows 103% over Q1 2014
Q1 2015 Surgical, Sports Medicine/Orthopedic revenue increases 125% over Q1 2014
Adjusted EBITDA of $8.8 million represents a 343% improvement over Q1 2014
Quarterly net income of $4.1 million or $0.04 per diluted share vs a net loss of $900,000 or $0.01 per diluted share in Q1 2014
Q1 2015 Cash Flow from Operating Activities of $4.2 million as compared to a negative $1.6 million in Q1 2014
Company increases full year guidance range from $175-$190 million to $180-$190 million
Significant progress made during quarter in gaining coverage from commercial as well as Medicaid payers
Company signs new building lease adding approximately 25,000 sq . ft . of space in support of planned growth
The chart of MiMedx shows the stock is in a Symmetrical Triangle (purple) pattern which is a consolidation pattern. The stock has yet to trigger a buy signal which would make an excellent entry imo .